Nissan Chemical Corporation
4021
Classement en actions
#2653
Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse... Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse business operations both domestically in Japan and across international markets, specializing in four key areas: chemicals, performance materials, agricultural chemicals, and pharmaceuticals. The company's expansive chemical product line includes the adhesive agent MELAMINE, a variety of high-purity chemicals, the urea solution AdBlue, and foundational industrial compounds such as ammonia, sulfuric acid, and nitric acid. Other specialized chemical offerings feature TEPIC (an epoxy compound), Melamine Cyanurate (a salt of melamine and isocyanuric acid), phenylphosphonic acid, and HI-LITE (a chlorinated isocyanurate). Additionally, Nissan Chemical manufactures the health food Nissan Reishi, OPTBEADS (composed of melamine-formaldehyde resin and silica), and FINEOXOCOL (a saturated fatty alcohol and acid). Within its performance materials division, the corporation develops crucial materials for display technologies, semiconductors, and various inorganic applications. Its agricultural chemicals segment supplies a broad range of products, including herbicides, insecticides, and fungicides, utilized on farmlands, golf courses, and public parks. This division also produces active pharmaceutical ingredients for animal antiparasitic medications. In the pharmaceutical sector, Nissan Chemical markets prescription drugs such as LIVALO, which is used to reduce cholesterol, and LANDEL and FINTE, both dual-action calcium channel blockers. Beyond its proprietary pharmaceutical products, the company offers custom manufacturing and process research services for pharmaceutical ingredients. Looking towards future innovation, Nissan Chemical is actively engaged in developing solutions across healthcare, information and communication materials, and environmental and energy materials. The company, which was previously known as Nissan Chemical Industries, Ltd., officially changed its name to Nissan Chemical Corporation in July 2018.
Prix de l'action
$53.70
Capitalisation boursière
$7.16B
Changement (1 jour)
0.35%
Changement (1 an)
54.95%
Pays
JP
Échange Nissan Chemical Corporation (4021)
Catégorie
Basic Materials
Ratio P/E pour Nissan Chemical Corporation (4021)
Ratio P/E au October 2026 TTM : 21.93
Selon les derniers rapports financiers et le cours de l'action de Nissan Chemical Corporation, le ratio P/E actuel (TTM) est de 21.93. À la fin de l’année 2024, le P/E de l’entreprise était de 21.19.
Historique du ratio P/E pour Nissan Chemical Corporation de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 21.93 | 54.56% |
| 2025 | 14.19 | -33.04% |
| 2024 | 21.19 | 3.05% |
| 2023 | 20.56 | -22.69% |
| 2022 | 26.59 | 4.27% |
| 2021 | 25.50 | 35.99% |
| 2020 | 18.75 | -27.31% |
| 2019 | 25.80 | 5.24% |
| 2018 | 24.52 | 18.77% |
| 2017 | 20.64 | 2.04% |
| 2016 | 20.23 | -7.36% |
| 2015 | 21.84 | 43.93% |
| 2014 | 15.17 | 14.55% |
| 2013 | 13.24 | 9.97% |
| 2012 | 12.04 | 6.34% |
| 2011 | 11.33 | -35.93% |
| 2010 | 17.68 | 23.27% |
| 2009 | 14.34 | 16.28% |
| 2008 | 12.33 | -38.88% |
| 2007 | 20.18 | -26.55% |
| 2006 | 27.47 | 77.51% |
| 2005 | 15.48 | -21.33% |
| 2004 | 19.67 | -11.06% |
| 2003 | 22.12 | -44.71% |
| 2002 | 40.00 | 28.48% |
| 2001 | 31.13 | -50.75% |
| 2000 | 63.21 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 50.73 | 131.29% |
TW
|
|
| 21.21 | -3.31% |
JP
|
|
| - | - |
DE
|
|
| -6.52 | -129.75% |
SA
|
|
| 12.24 | -44.21% |
CN
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.